Impact of Biosimilars

Impacting the entire Canadian healthcare system

We’re committed to the development of biosimilars because of the additional treatment options they provide to patients and the positive impact they can have on the entire healthcare system.

At a time when healthcare costs are rising, we aspire to contribute to a more sustainable healthcare system. Our goal is to provide biosimilar options that can offer cost savings to patients and the healthcare system.

Impacting every Amgen patient, every time

At the heart of Amgen’s commitment to biosimilars is our mission to serve patients. High-quality, reliably supplied biosimilars are anticipated to offer additional treatment options for patients—and we believe that we bring the high-quality science to this new space in health care.

We want to help patients access the medicines they need earlier in their disease progression. With increased availability of lower-cost biosimilars, it may now be easier to choose the right medicine at the right time.

Next: Therapeutic
Area Commitment

Previous: Significant
Investment